Veteran banker Ashok Vaswani assumes charge as Kotak Mahindra Bank’s MD, CEO
时间:2024-06-26 12:31:55 阅读(143)
Kotak Mahindra Bank on Monday said veteran banker Ashok Vaswani has assumed charge as the managing director (MD) and CEO of the bank.
He replaced Dipak Gupta, who was the interim MD and CEO, following founder director Uday Kotak stepping down as the head of the bank, effective September 1, 2023.
The Reserve Bank of India (RBI) in October 2023 approved the appointment of Vaswani as the bank’s MD and CEO for a period of three years.
Like Uday Kotak, he is also an alumnus of the Sydenham College of Commerce and Economics. Vaswani is also a qualified chartered accountant and company secretary.
Vaswani had worked with Barclays in the recent past. Prior to this, Vaswani was the President of Pagaya Technologies Ltd — a US-Israeli AI Fintech player.
He has a proven track record spanning three-and-a-half decades, initially at Citigroup and more recently at Barclays.
Besides, the regulatory filing said CS Rajan has assumed charge of chairman of the bank.
Rajan’s appointment as the part-time chairman of the board follows the retirement of Prakash Apte, whose term expired on December 31, 2023.
Rajan was appointed as an Independent Director on the board of the bank with effect from October 22, 2022, the filing said.
An IAS officer of the 1978 batch, he retired as Chief Secretary of the Rajasthan government in 2016.
Meanwhile, the filing said, Eli Leenaars (full name: Cornelis Petrus Adrianus Joseph Leenaars) has assumed the position as an Independent Director of the Bank, with effect from January 1, 2024.
猜你喜欢
- LPU student’s start-up receives Rs 1
- Mamaearth IPO 1000x valuation raises concerns; ‘Another Paytm in the making’-
- IRM Energy IPO opens, GMP rises over 13%; should you subscribe to the issue-
- Investors wealth climb over Rs 5 lakh cr in two days of market recovery
- Sebi’s upstreaming diktat may raise concentration risks
- Sensex ends 1% up on weekly F&O expiry, Nifty support at 17450, D-St gains for 4th day straight; CPI, IIP eyed
- Mankind Pharma IPO opens for subscription, GMP rises; should you subscribe to Rs 4500-crore public issue-
- IT Q4FY23 results preview- IT services cos to witness moderated growth in revenue, margins
- Sebi settles with individual case of alleged unfair trade practices